182 related articles for article (PubMed ID: 16340628)
1. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.
Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB
J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628
[TBL] [Abstract][Full Text] [Related]
2. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
3. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
4. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
5. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
6. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
7. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
[TBL] [Abstract][Full Text] [Related]
9. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.
Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281
[TBL] [Abstract][Full Text] [Related]
10. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
[TBL] [Abstract][Full Text] [Related]
12. [Outpatient monitoring of oesophageal pH with a catheter-free pH-meter (Bravo System). A Study of tolerance, safety and efficacy].
Martínez de Haro LF; Munitiz V; Ortiz A; Ruiz de Angulo D; Navarro MD; Parrilla P
Cir Esp; 2008 Oct; 84(4):201-9. PubMed ID: 18928770
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory esophageal pH monitoring using a wireless system.
Pandolfino JE; Richter JE; Ours T; Guardino JM; Chapman J; Kahrilas PJ
Am J Gastroenterol; 2003 Apr; 98(4):740-9. PubMed ID: 12738450
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
15. Two years' experience of using the Bravo wireless oesophageal pH monitoring system at a single UK tertiary centre.
Rao NM; Campbell DI; Rao P
Acta Paediatr; 2017 Feb; 106(2):312-315. PubMed ID: 27862298
[TBL] [Abstract][Full Text] [Related]
16. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
Doma S; Paladugu S; Parkman HP; Friedenberg FK
Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
[TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
18. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?
Bechtold ML; Holly JS; Thaler K; Marshall JB
World J Gastroenterol; 2007 Aug; 13(30):4091-5. PubMed ID: 17696227
[TBL] [Abstract][Full Text] [Related]
19. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
[TBL] [Abstract][Full Text] [Related]
20. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
